TrialTrials2010

Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial).

Petr Ostadal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.